Cargando…
Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era
Background: Use of lungs donated after circulatory death (DCD) has expanded, but changes in donor/recipient characteristics and comparison to brain dead donors (DBD) has not been studied. We examined the evolution of the use of DCD lungs for transplantation and compare outcomes to DBD lungs. Methods...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013720/ https://www.ncbi.nlm.nih.gov/pubmed/35444490 http://dx.doi.org/10.3389/ti.2022.10172 |
_version_ | 1784688057275908096 |
---|---|
author | Bobba, Christopher M. Whitson, Bryan A. Henn, Matthew C. Mokadam, Nahush A. Keller, Brian C. Rosenheck, Justin Ganapathi, Asvin M. |
author_facet | Bobba, Christopher M. Whitson, Bryan A. Henn, Matthew C. Mokadam, Nahush A. Keller, Brian C. Rosenheck, Justin Ganapathi, Asvin M. |
author_sort | Bobba, Christopher M. |
collection | PubMed |
description | Background: Use of lungs donated after circulatory death (DCD) has expanded, but changes in donor/recipient characteristics and comparison to brain dead donors (DBD) has not been studied. We examined the evolution of the use of DCD lungs for transplantation and compare outcomes to DBD lungs. Methods: The SRTR database was used to construct three 5-year intervals. Perioperative variables and survival were compared by era and for DCD vs. DBD. Geographic variation was estimated using recipient permanent address. Results: 728 DCD and 27,205 DBD lung transplants were identified. DCD volume increased from Era 1 (n = 73) to Era 3 (n = 528), representing 1.1% and 4.2% of lung transplants. Proportionally more DCD recipients were in ICU or on ECMO pre-transplant, and had shorter waitlist times. DCD donors were older, had lower PaO2/FiO2 ratios compared to DBD, more likely to be bilateral, had longer ischemic time, length of stay, post-op dialysis, and increased use of lung perfusion. There was no difference in overall survival. Geographically, use was heterogeneous. Conclusion: DCD utilization is low but increasing. Despite increasing ischemic time and transplantation into sicker patients, survival is similar, which supports further DCD use in lung transplantation. DCD lung transplantation presents an opportunity to continue to expand the donor pool. |
format | Online Article Text |
id | pubmed-9013720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90137202022-04-19 Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era Bobba, Christopher M. Whitson, Bryan A. Henn, Matthew C. Mokadam, Nahush A. Keller, Brian C. Rosenheck, Justin Ganapathi, Asvin M. Transpl Int Health Archive Background: Use of lungs donated after circulatory death (DCD) has expanded, but changes in donor/recipient characteristics and comparison to brain dead donors (DBD) has not been studied. We examined the evolution of the use of DCD lungs for transplantation and compare outcomes to DBD lungs. Methods: The SRTR database was used to construct three 5-year intervals. Perioperative variables and survival were compared by era and for DCD vs. DBD. Geographic variation was estimated using recipient permanent address. Results: 728 DCD and 27,205 DBD lung transplants were identified. DCD volume increased from Era 1 (n = 73) to Era 3 (n = 528), representing 1.1% and 4.2% of lung transplants. Proportionally more DCD recipients were in ICU or on ECMO pre-transplant, and had shorter waitlist times. DCD donors were older, had lower PaO2/FiO2 ratios compared to DBD, more likely to be bilateral, had longer ischemic time, length of stay, post-op dialysis, and increased use of lung perfusion. There was no difference in overall survival. Geographically, use was heterogeneous. Conclusion: DCD utilization is low but increasing. Despite increasing ischemic time and transplantation into sicker patients, survival is similar, which supports further DCD use in lung transplantation. DCD lung transplantation presents an opportunity to continue to expand the donor pool. Frontiers Media S.A. 2022-04-04 /pmc/articles/PMC9013720/ /pubmed/35444490 http://dx.doi.org/10.3389/ti.2022.10172 Text en Copyright © 2022 Bobba, Whitson, Henn, Mokadam, Keller, Rosenheck and Ganapathi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Health Archive Bobba, Christopher M. Whitson, Bryan A. Henn, Matthew C. Mokadam, Nahush A. Keller, Brian C. Rosenheck, Justin Ganapathi, Asvin M. Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era |
title | Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era |
title_full | Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era |
title_fullStr | Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era |
title_full_unstemmed | Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era |
title_short | Trends in Donation After Circulatory Death in Lung Transplantation in the United States: Impact Of Era |
title_sort | trends in donation after circulatory death in lung transplantation in the united states: impact of era |
topic | Health Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013720/ https://www.ncbi.nlm.nih.gov/pubmed/35444490 http://dx.doi.org/10.3389/ti.2022.10172 |
work_keys_str_mv | AT bobbachristopherm trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera AT whitsonbryana trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera AT hennmatthewc trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera AT mokadamnahusha trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera AT kellerbrianc trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera AT rosenheckjustin trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera AT ganapathiasvinm trendsindonationaftercirculatorydeathinlungtransplantationintheunitedstatesimpactofera |